What are the appropriate management and manifestations of cord compression in patients, particularly those with a history of cancer, trauma, or degenerative spinal conditions?

Spinal Cord Compression: Clinical Manifestations and Management

Clinical Manifestations

Back pain is the cardinal presenting symptom, occurring in 90% of patients with spinal cord compression, though it is not specific for malignant cord compression. 1

Key Symptoms by Category

Motor Dysfunction:

• Motor weakness and gait deterioration develop in approximately 67% of patients before diagnosis 1
• Up to 50% of patients are unable to walk at the time of presentation 1
• Progressive weakness typically ascends from lower extremities 2, 1

Sensory Changes:

• Numbness, paresthesias, and sensory level deficits are common 1
• Radicular pain extending along nerve root distributions from the spine 1
• Sensory changes often precede motor deficits 2

Autonomic Dysfunction:

• Bladder retention, bowel dysfunction, and sphincter disturbances occur in 48% of patients 1
• These symptoms indicate advanced compression and portend worse outcomes 2, 1

---

Immediate Diagnostic Approach

MRI of the entire spine—not just the symptomatic level—should be performed emergently for any patient with neurologic symptoms and a history of cancer. 2, 3, 1

Imaging Characteristics

• MRI sensitivity: 0.44-0.93; specificity: 0.90-0.98 3, 1
• Myelography with CT is an alternative when MRI is contraindicated, with sensitivity 0.71-0.97 and specificity 0.88-1.00 3, 1
• Complete spine imaging is essential because multiple levels may be involved 1

---

Emergency Management Algorithm

Step 1: Immediate Corticosteroid Therapy

Initiate high-dose dexamethasone 96 mg IV daily immediately upon clinical suspicion, even before radiographic confirmation, then taper over 14 days. 3, 1

• High-dose dexamethasone before radiotherapy significantly improves ambulation rates (81% vs 63% at 3 months) compared to no corticosteroids 3
• This carries significant toxicity risk but is justified by the potential for irreversible neurologic decline 3
• Ambulatory patients without deficits do not require dexamethasone but need education about warning symptoms 2

Step 2: Determine Treatment Pathway

Surgery followed by radiotherapy is indicated for patients meeting ALL of the following criteria: 3, 1

• Single level of compression
• Neurologic deficits present for <48 hours
• Predicted survival ≥3 months
• Age <65 years

Absolute surgical indications regardless of other factors include: 3, 1

• Bony retropulsion or bone fragments causing cord compression
• Frank spinal instability
• Unknown primary tumor requiring tissue diagnosis

Surgery plus radiotherapy maintains ambulation longer than radiotherapy alone (P=0.006). 3

Step 3: Radiotherapy Protocol

For patients not meeting surgical criteria, radiotherapy alone is the primary treatment with a standard regimen of 30 Gy in 10 fractions. 3, 1

• Alternative regimens include 37.5 Gy in 15 fractions, 40 Gy in 20 fractions, or 28 Gy in 7 fractions—no regimen demonstrates superiority 3
• Pain relief may be delayed up to 2 weeks following treatment 3
• Patients who undergo surgery should receive radiotherapy post-operatively once healing has occurred 3

---

Prognostic Factors That Determine Outcomes

Pretreatment ambulatory status is the single strongest predictor of post-treatment function and survival. 2, 3, 1

Functional Recovery by Pretreatment Status

• Ambulatory patients: 96-100% chance of remaining ambulatory after treatment 3, 1
• Paraparetic patients: Only 18-30% chance of regaining walking ability 1
• Paraplegic patients: Only 2-6% chance of regaining ambulatory function 3, 1

Patients with slower motor deficit development (>14 days) have significantly better functional outcomes than those with rapid progression (<14 days, P<0.01). 1

---

Critical Pitfalls and Time-Sensitive Considerations

70% of patients experience loss of neurologic function between symptom onset and treatment initiation, with two-thirds of delays attributed to patients not recognizing symptoms as urgent. 3

Common Errors to Avoid

• Delaying treatment minimizes the chance of neurologic recovery—manage patients to minimize treatment delay 1
• Missing unstable fractures by performing inadequate neurological examination 4
• Imaging only the symptomatic level rather than the entire spine 1
• Waiting for radiographic confirmation before initiating dexamethasone 3, 1

High-Risk Populations Requiring Vigilance

Lung cancer, prostate cancer, and breast cancer account for 65% of spinal cord compression episodes, with other high-risk malignancies including myeloma and renal cell carcinoma. 1

• Asymptomatic patients with extensive bone metastases (>20 lesions) have a 32% risk of cord compression before hormone therapy and 44% after 24 months of treatment 1
• These patients warrant consideration for prophylactic irradiation of subclinical compression 2

---

Adjunctive Management

Bone-directed therapy such as zoledronic acid 4 mg IV over 15 minutes monthly or pamidronate 90 mg IV over 2 hours monthly should be initiated for bone disease. 3

• Vertebroplasty or kyphoplasty may be used for severe back pain from vertebral compression fractures 3
• Supportive treatments including analgesia, antiemetics, laxatives, and bladder care should be considered where appropriate 2

Salvage Options

• Patients who deteriorate neurologically or recompress after radiotherapy should be considered for surgery 2
• Patients who recompress in-field after radiotherapy may be considered for reirradiation, especially if it has been more than 6 weeks since completion of their last course 2